Founder and chair of the APCCC consensus conference that guides advanced prostate cancer management worldwide.
Silke Gillessen (IOSI, Bellinzona) founded the Advanced Prostate Cancer Consensus Conference, whose biennial reports are the most widely used expert guidance on managing advanced prostate cancer where trial evidence is lacking. She was a lead investigator in STAMPEDE and in trials of PSMA radioligand therapy and helped establish the Swiss Group for Clinical Cancer Research GU programme.
Shares STAMPEDE: adding abiraterone to hormone therapy at diagnosis of advanced prostate cancer, STAMPEDE, Prostate cancer.
Shares STAMPEDE, Prostate cancer and the tag prostate.
Shares European Urology, Prostate cancer and the tag prostate.
Shares European Urology, Prostate cancer and the tag prostate.
Shares European Urology, Prostate cancer.
Shares Prostate cancer and the tag prostate.
Shares Prostate cancer and the tag prostate.
Shares Prostate cancer and the tag prostate.